Sibio v Abbott Diabetes Care (CoA, 27 February 2026)
| Date | 27 February 2026 |
|---|---|
| Court | CoA |
| Division | Luxembourg (LU) |
| Type of action | Generic Order |
| Case number(s) | UPC_CoA_884/2025 |
| Registry reference | UPC-COA-0000884/2025 |
| Parties | Sibio Technology Limited v. Abbott Diabetes Care Inc. |
Official decision (PDF) · UPC registry entry
Case timeline
- 14 August 2026 : Sibio v Abbott Diabetes Care (CoA, 14 August 2026) UPC-COA-0000884/2025
Dhenne Avocats represents claimants and defendants in European patent disputes before the Unified Patent Court, including the Paris divisions.
Dhenne Avocats · 10 October 2026
Our analysis
Summary
In an order of 27 February 2026 (UPC_CoA_884/2025), the judge-rapporteur of the UPC Court of Appeal rejected Sibio Technology Limited’s request under Rule 36 for a further exchange of written pleadings in its appeal against the Paris Central Division’s dismissal of its revocation action against Abbott Diabetes Care Inc.’s EP 3 831 283. Sibio relied on the six auxiliary requests maintained by Abbott in its statement of response. The order clarifies the status on appeal of auxiliary requests admitted at first instance and closes the written procedure.
Question
Does a respondent that maintains on appeal auxiliary requests to amend admitted at first instance give the appellant a right to a written reply?
Decision
The auxiliary requests, filed and admitted at first instance, form part of the basis of the appeal under Rules 222.1 and 222.2 unless Abbott withdraws them, and did not need to be refiled (paragraphs 7 to 9). Maintaining them is not a conditional cross-appeal, as Abbott seeks no different outcome from the decision under appeal (paragraph 10). Sibio could have addressed the requests not decided at first instance in its grounds of appeal (paragraph 11), and Abbott had not amended them (paragraph 12). The fact that further pleadings would not disrupt the timetable is not in itself a sufficient reason to allow them (paragraph 13), and refusing them does not breach the right to be heard, since Sibio can respond at the oral hearing (paragraph 14). The written procedure was closed and the oral procedure opened.
Key points for practice
- An appellant should address in its grounds of appeal the respondent’s auxiliary requests admitted at first instance, even if they were not decided there: it cannot count on a written reply (paragraphs 9 to 14).
Provisions applied
- Rules of Procedure
- Rules 35(a), 36, 220.1(a), 222.1, 222.2, 226 and 333.1
Related decisions
Prepared by Dhenne Avocats from the official decision, consulted on 10 October 2026. The database is updated every week, on Friday. Only the official text is authoritative.
Decisions in the same proceedings
Going further
Lexicon: UPC Court of Appeal.
Dhenne Avocats blog: UPC Appeals: What the Numbers Show.
Source and translations
- Official source
- Unified Patent Court registry link recorded in the record
- Original language
- not recorded
- Translation available
- no translation recorded the firm’s French record is a summary, not a translation
- Date checked
- not recorded
Follow this case
Proceedings, related decisions, appeals, parties and patents as recorded in the registry and in the Dhenne Avocats corpus. Each link states its source.
Parties
- defendantAbbott Diabetes Care Inc.36 decisions in the corpusFollow this party
- claimantSibio Technology Limited10 decisions in the corpusFollow this party
Decisions in the same proceedings and documented appeals
- 27 February 2026 Sibio v Abbott Diabetes Care (CoA, 27 February 2026) Generic Order · UPC_CoA_884/2025
- 14 August 2026 Sibio v Abbott Diabetes Care (CoA, 14 August 2026) Appeal · UPC_CoA_884/2025 · appeal, first-instance number cited in the decision
La cour d'appel rejette l'appel de Sibio : les revendications 1 et 15 du brevet EP 3 831 283 ne contiennent pas d'élément ajouté malgré l'omission de l'étanchéité élastomère, et l'activité inventive n'est pas remise en cause au départ de WO 2011/119896 combiné à US 2008/255440.
What the record states
- Nature of the act
- Generic Order
- Outcome (Dhenne Avocats summary)
- La demande de Sibio tendant à des écritures supplémentaires est rejetée : les requêtes subsidiaires d'Abbott admises en première instance font partie de la base de l'appel sans constituer un appel incident, et Sibio pouvait les discuter dans son mémoire d'appel puis à l'audience.
- Appeal
- Decision of the Court of Appeal.
- Instance
- Court of Appeal decision.
Patents mentioned
EP 3 831 283mentioned in: Dhenne Avocats analysis Follow this patent
Related decisions cited in the analyses
- Sibio v Abbott Diabetes Care (CoA, 14 August 2026) cited in this record
- Sibio Technology v Abbott Diabetes Care (CFI, 21 July 2025) cited in this record
Patents and standards
Receive an alert
Weekly summary of new records and substantive updates matching what you follow. Address confirmed by email, unsubscribe at any time, one email per week even where several of your follows match.